Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer

被引：3

作者：

Reese, Adam C. ^{[1
]}

Hardin, Jill ^{[2
,3
]}

Cheng, Iona ^{[4
]}

Casey, Graham ^{[5
]}

Witte, John S. ^{[1
,2
,3
]}

机构：

[1] Univ Calif San Francisco, Dept Urol, 1450 3rd St, San Francisco, CA 94158 USA

[2] Univ Calif San Francisco, Epidemiol & Biostat, San Francisco, CA 94158 USA

[3] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA

[4] Univ Hawaii, Canc Res Ctr Hawaii, Epidemiol Program, Honolulu, HI 96813 USA

[5] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90033 USA

来源：

PHARMACEUTICALS | 2010年 / 3卷 / 10期

基金：

美国国家卫生研究院;

关键词：

prostatic neoplasms; non-steroidal anti-inflammatory agents; aspirin; genetic variation; single nucleotide polymorphism;

D O I：

10.3390/ph3103127

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Increasing evidence suggests that prostatic inflammation plays a key role in the development of prostate cancer. It remains controversial whether non -steroidal antiinflammatory drugs (NSAIDs) reduce the risk of prostate cancer. Here, we investigate how a previously reported inverse association between NSAID use and the risk of aggressive prostate cancer is modulated by variants in several inflammatory genes. We found that NSAIDs may have differential effects on prostate cancer development, depending on one's genetic makeup. Further study of these inflammatory pathways may clarify the mechanisms through which NSAIDs impact prostate cancer risk.

引用

页码：3127 / 3142

页数：16

共 63 条

[11] Antibiotic and anti-inflammatory use and the risk of prostate cancer
Daniels N.A.
Chen Y.-H.
Bent S.
[J]. BMC Research Notes, 2 (1)
[12] Dasgupta K, 2006, CANCER J, V12, P130
[13] Inflammation in prostate carcinogenesis
De Marzo, Angelo M.
Platz, Elizabeth A.
Sutcliffe, Siobhan
Xu, Jianfeng
Gronberg, Henrik
Drake, Charles G.
Nakai, Yasutomo
Isaacs, William B.
Nelson, William G.
[J]. NATURE REVIEWS CANCER, 2007, 7 (04) : 256 - 269
[14] Celecoxib up-regulates the expression of the ζ chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer
Ferrandina, G
Ranelletti, FO
Legge, F
Salutari, V
Martinelli, E
Fattorossi, A
Lorusso, D
Zannoni, G
Vellone, V
Paglia, A
Scambia, G
[J]. CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2055 - 2060
[15] Association of Nonsteroidal Anti-inflammatory Drugs, Prostate Specific Antigen and Prostate Volume
Fowke, Jay H.
Motley, Saundra S.
Smith, Joseph A., Jr.
Cookson, Michael S.
Concepcion, Raoul
Chang, Sam S.
Byerly, Susan
[J]. JOURNAL OF UROLOGY, 2009, 181 (05) : 2064 - 2070
[16] Expression of Toll-Like Receptor 4 in the Prostate Gland and Its Association With the Severity of Prostate Cancer
Gatti, Gerardo
Quintar, Amado A.
Andreani, Virginia
Nicola, Juan P.
Maldonado, Cristina A.
Maria Masini-Reviso, Ana
Rivero, Virginia E.
Maccioni, Mariana
[J]. PROSTATE, 2009, 69 (13) : 1387 - 1397
[17] Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO
[18] 2-G
[19] Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US
Habel, LA
Zhao, W
Stanford, JL
[J]. CANCER CAUSES & CONTROL, 2002, 13 (05) : 427 - 434
[20] The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
Hsu, AL
Ching, TT
Wang, DS
Song, XQ
Rangnekar, VM
Chen, CS
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) : 11397 - 11403

← 1 2 3 4 5 6 7 →